Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare FSS Plan Would Cost VA Over $500 Mil., Rep. Stearns Says

Executive Summary

Extending federal supply schedule prices for pharmaceuticals to the Medicare population could cost the Department of Veterans Affairs half a billion dollars annually, Rep. Stearns (R-Fla.) told a House Commerce/Health & Environment Subcommittee hearing on seniors' access to prescription drugs Oct. 4.

You may also be interested in...



VA Drug Coverage Expansion Proposed; Fallback If Medicare Rx Fails?

A proposal by Senate Veterans Affairs Committee Chairman Arlen Specter (R-Pa.) to offer all Medicare-eligible veterans access to VA drug prices is the latest possible senior drug coverage fallback bill to be introduced in Congress

VA Drug Coverage Expansion Proposed; Fallback If Medicare Rx Fails?

A proposal by Senate Veterans Affairs Committee Chairman Arlen Specter (R-Pa.) to offer all Medicare-eligible veterans access to VA drug prices is the latest possible senior drug coverage fallback bill to be introduced in Congress

Pfizer Adds Urgency To Call For Drug Benefit: 107th Congress Is Well-Aligned

Pfizer is pressing for Congressional action on expanded drug benefits for the elderly in its early meetings with the Republican health committee leaders in the 107th Congress.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel